Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients
Fluoroquinolones (FQs) are potential drugs that inhibit DNA synthesis and are used in the treatment of multidrug-resistant tuberculosis (TB) and short-term anti-TB regimens. In recent years, a high proportion ...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Saba Kabir, Zarfishan Tahir, Nadia Mukhtar, Muhammad Sohail, Muhammad Saqalein and Abdul Rehman Tags: Research article Source Type: research